跳至主要内容
临床试验/NCT05933226
NCT05933226招募中不适用

A Stepped Care, Peer-Delivered Intervention to Improve ART Adherence and SUD in Primary Care

University of Maryland, College Park2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2023年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
160
试验地点
2
主要终点
Changes in HIV Medication Adherence

研究概览

简要总结

The purpose of this study is to evaluate a stepped care behavioral intervention for HIV medication adherence and substance use ("Khanya") integrated into an HIV primary care setting in South Africa. The intervention is specifically designed to be implemented by non-specialist counselors with lived substance use experience (i.e., peers), using a task sharing, stepped care model in local primary care clinics. The Khanya stepped care package will be compared to usual care, enhanced with referral to a local outpatient substance use treatment program (Enhanced Standard of Care - ESOC) over 12 months.

详细描述

South Africa is home the highest number of people living with HIV in the world and has a high burden of substance use disorder (SUD). Globally, a SUD treatment gap exists, particularly in low and middle-income countries (LMICs), such as South Africa, where only 1-4% of individuals receive minimally adequate treatment. Workforce shortages are also severe in LMICS, and countries such as South Africa have responded to this through the implementation of task sharing models to expand access to antiretroviral therapy (ART) and mental health services. However, efforts to implement task shared, SUD treatment and ART adherence interventions that can be feasibly and sustainably integrated into primary care are limited. Therefore, the purpose of this study is to help fill this gap in care by evaluating Khanya, a peer-delivered, behavioral intervention to improve HIV care outcomes and reduce substance use. The present study is a hybrid effectiveness-implementation trial designed to evaluate Khanya compared to usual care, enhanced with referral to a local outpatient substance use treatment program (Enhanced Standard of Care - ESOC) over 12 months. To provide care for those most in need, participants will be patients with HIV who are struggling with ART adherence and have elevated SUD risk. In this study, Khanya will be delivered as a stepped-care package in which the least resource-intensive part of the intervention (i.e., a single session problem solving intervention for HIV medication adherence) will be delivered first. Only individuals randomized to the Khanya intervention who are still struggling with HIV medication adherence after the first session will be stepped up to receive the more comprehensive, resource-intensive part of the intervention (i.e., six additional sessions of the intervention). Primary effectiveness outcomes in this clinical trial include ART adherence and SUD outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV positive and on ART
  • ≥18 years of age
  • At least moderate substance use risk in the past 3 months for at least one non-tobacco substance (measured by the WHO- ASSIST: score ≥11 for alcohol, ≥4 for non-tobacco drugs)
  • ART nonadherence and/or risk of virologic failure, defined as at least one of the following in the past 12 months 1) re-engaging in care after ≥1 month of being out of care (confirmed by pharmacy refill data) 2) ≥1 episodes of VL >400 copies/mL 3) on second- or third-line ARTs.

排除标准

  • Severe risk/likely dependence for opiates (WHO ASSIST score >26) because opiate substitution therapy is largely not available
  • Severe alcohol dependence symptoms that may warrant medical management of potential withdrawal symptoms/stabilization prior to study participation
  • Inability to provide informed consent or complete study procedures in isiXhosa or English
  • In third trimester of pregnancy during baseline
  • Currently enrolled in another study or treatment program focused on substance use (including Matrix) or ART adherence.
  • Untreated or undertreated major mental illness that would interfere with study procedures

结局指标

主要结局

Changes in HIV Medication Adherence

时间窗: Assessed from baseline through 12-month assessment

Percentage of prescribed antiretroviral therapy (medications) taken as measured by real time wireless monitoring device (Wisepill)

Biological Measure of Substance Use

时间窗: Assessed from baseline across 3-, 6-, and 12-month assessments

Biomarker-verified substance use

次要结局

  • Biological Measure of Adherence(Assessed from baseline across 3-, 6-, and 12-month assessments)
  • HIV Clinic Attendance(Assessed from baseline across 3-, 6-, and 12-month assessments)
  • Changes in Self-Reported Substance Use(Assessed from baseline across 3-, 6-, and 12-month assessments)
  • Employment Status Questionnaire(Assessed from baseline across 3-, 6-, and 12-month assessments)
  • HIV Viral Load(Assessed from baseline across 6-, and 12-month assessments)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验